Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach

Pediatr Radiol. 2019 Oct;49(11):1391-1403. doi: 10.1007/s00247-019-04457-7. Epub 2019 Oct 16.

Abstract

Differentiated thyroid cancer in children is a rare disease, accounting for only 1.4% of all pediatric malignancies. The diagnosis, biological behavior and treatment of differentiated thyroid cancer in children is different from that in adults. While there are many unresolved issues regarding approaches to management of differentiated thyroid cancer in the pediatric population, there is near universal consensus that treatment of this disease, which includes total thyroidectomy, central lymph node dissection at the time of initial surgery in those with nodal metastases, and the possible use of iodine-131 radiotherapy, is best performed by specialists including high-volume endocrine surgeons and experts with experience in calculating and administering radioactive iodine in children, when deemed appropriate.

Keywords: Carcinoma; Children; Complications; Iodine-131 therapy; Long-term follow-up; Nuclear medicine; Thyroid; Thyroidectomy; Ultrasound.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Lymph Node Excision
  • Lymphatic Metastasis / diagnostic imaging*
  • Thyroid Neoplasms / diagnostic imaging*
  • Thyroid Neoplasms / therapy*
  • Thyroidectomy

Substances

  • Iodine Radioisotopes